This Biotech Stock 135% Jump Trims $44M: What Now Today
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Explore when bonds may be preferred over the Sp500 in retirement and how a cautious mix can protect assets while supporting withdrawals. This intro covers key timing considerations and conservative principles.
23,766 articlesA biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Tim Cook used the China Development Forum to stress collaboration with Chinese partners as Beijing intensifies policy...
A global four-week contest stitches together AI personas, crypto rewards, and influencer intrigue. Here’s how fake in...
Credit conditions are tightening ahead of any Fed move, driven by higher bond yields and a wave of AI financing. Inve...
Two Nevada lawmakers demand a comprehensive plan to fix safety oversight gaps tied to Elon Musk's Boring Co. tunnelin...
BlackRock's Larry Fink presents two stark paths for oil and markets tied to the Iran conflict, challenging households...
JPMorgan Chase CEO Jamie Dimon warned that U.S. defense procurement has shifted toward European-style bureaucracy, po...
When a chief executive sells a large block of shares, investors understandably take note. This guide breaks down what...
Two big reasons explain why the fear around IBM's COBOL future might be overstated. This piece breaks down why COBOL ...
In his first week as Disney’s leader, Josh D’Amaro confronts three major headwinds that could set the tone for his te...
A fresh pullback can create smart entry points. This guide highlights my top 3 financial stocks after latest market p...
When a mining stock pops, traders look beyond a single catalyst. This article breaks down why coeur mining stock popp...